Form 8-K - Current report:
SEC Accession No. 0001628908-25-000018
Filing Date
2025-02-20
Accepted
2025-02-20 16:18:49
Documents
16
Period of Report
2025-02-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evh-20250220.htm   iXBRL 8-K 30396
2 EX-99.1 a2024q4exhibit991.htm EX-99.1 445770
7 evhnewlogo.jpg GRAPHIC 30853
  Complete submission text file 0001628908-25-000018.txt   711701

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evh-20250220.xsd EX-101.SCH 2092
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evh-20250220_def.xml EX-101.DEF 14966
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evh-20250220_lab.xml EX-101.LAB 26430
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evh-20250220_pre.xml EX-101.PRE 15620
18 EXTRACTED XBRL INSTANCE DOCUMENT evh-20250220_htm.xml XML 2847
Mailing Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209
Business Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209 571-389-6000
Evolent Health, Inc. (Filer) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37415 | Film No.: 25645678
SIC: 8741 Services-Management Services
(CF Office: 07 Trade & Services)